Cargando…

Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease

Early diagnosis of Alzheimer’s disease (AD) is of paramount importance in preserving the patient’s mental and physical health in a fairly manageable condition for a longer period. Reliable AD detection requires novel biomarkers indicating central nervous system (CNS) degeneration in the periphery. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudák, Anett, Letoha, Annamária, Vizler, Csaba, Letoha, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955174/
https://www.ncbi.nlm.nih.gov/pubmed/35328830
http://dx.doi.org/10.3390/ijms23063407